In recent years, peptide research has seen exceptional growth across medicine, biotechnology, chemical biology and therapeutic discovery. Peptide therapeutics offer highly selective mechanisms of action and closely mimic natural biochemical pathways — resulting in excellent safety and efficacy profiles. As a result, both industry and academia are renewing their interest in peptide-based therapies.

The future of peptide R&D continues to look very strong. Global regulatory approvals for peptide drugs grow year after year — with more than 60 approved peptide-based therapeutics already available across North America, Europe, and the Asia–Pacific region, and over 150 peptide candidates currently in clinical trials. Increasing demand is driving rapid market growth, with the global peptide therapeutics market estimated at ~US $24 billion.

Peptides function as highly potent signaling molecules and support R&D in key therapeutic areas including metabolic diseases, oncology, infectious diseases, and inflammatory disorders. While traditional peptide drug development has been limited by short plasma half-life and poor oral bioavailability, modern design strategies (primary structure modifications, secondary structure optimization, half-life extension technologies, etc.) are addressing these challenges and unlocking the potential of peptide-based therapeutics.

Beyond therapeutic development, natural and synthetic peptides are used widely in drug discovery, epitope mapping, vaccine development, and numerous chemical biology applications.

---

Our Peptide Capabilities

VivaMed Sciences offers comprehensive custom peptide synthesis services, with expertise in both liquid-phase (LPPS) and solid-phase peptide synthesis (SPPS). Our proprietary redox peptide ligation technology enables highly efficient synthesis of longer and more complex peptides — translating into shorter delivery timelines and higher success rates.

What we offer:

• Custom synthesis of API peptides, cosmetic peptides, and peptide libraries (research to commercial purity grades)

• Scale capability ranging from milligram to kilogram quantities

• Competitive pricing supported by in-house production of key coupling reagents

• Fluorescent dye conjugation (BODIPY FL, Fluorescein, Cyanine 3, etc.) to support protein interaction studies, receptor–ligand binding, enzyme activity assays, and cellular imaging

Fluorescent Dye Conjugation

Fluorescently labeled peptides are powerful tools for probing biological systems. We provide custom conjugation services using a range of dyes, including:

We offer ready-to-use BODIPY FL conjugated antibodies, peptides, proteins, and tracers, as well as reactive dye forms and labelling kits that enable you to generate your own labeled peptides, proteins, or probes.